Ribomic (TSE:4591) Interest Expense: 円-10.18 Mil (TTM As of Mar. 2026)


TSE:4591 Ribomic Inc TSE:4591
25 GF Score
Price 円63.00
! 3 Warning Signs
View Full Analysis

What is Ribomic Interest Expense?

Ribomic TSE:4591 +3.28% 25 Interest Expense is 円-10.18 Mil as of Mar. 2026. GuruFocus rates TSE:4591 with a GF Score™ of 25/100. The stock has 3 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Ribomic's interest expense for the six months ended in Mar. 2026 was 円 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was 円-10.18 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Ribomic's Operating Income for the six months ended in Mar. 2026 was 円 -668.90 Mil. Ribomic's Interest Expense for the six months ended in Mar. 2026 was 円 0.00 Mil. Ribomic has no long-term debt (1). The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Ribomic  (TSE:4591) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Ribomic's Interest Expense for the six months ended in Mar. 2026 was 円0.00 Mil. Its Operating Income for the six months ended in Mar. 2026 was 円-668.90 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Mar. 2026 was 円0.00 Mil.

Ribomic's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Ribomic had no long-term debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Ribomic Interest Expense Historical Data

* Premium members only.

The historical data trend for Ribomic's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ribomic Interest Expense Chart

Ribomic Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.61 -10.31 -3.68 -3.86 -13.42

Ribomic Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.32 -1.84 -0.29 -10.18 0.00
TSE:4591
25GF Score
Ribomic Inc TSE:4591
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ribomic Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円-10.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of 円-10.18 Mil mean?
Ribomic (TSE:4591) has a Interest Expense of 円-10.18 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Ribomic and its competitors.
Is Ribomic's Interest Expense too high?
Ribomic's current Interest Expense is 円-10.18 Mil. Overall, Ribomic has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Ribomic's Interest Expense compare to VRTX and REGN?
Ribomic's Interest Expense of 円-10.18 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Ribomic and its competitors. Ribomic's current Interest Expense is 円-10.18 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ribomic stock overvalued right now?
Ribomic (TSE:4591) has a current Interest Expense of 円-10.18 Mil. The current Interest Expense is 円-10.18 Mil. Ribomic's overall GF Score™ is 25/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Ribomic (TSE:4591), the current Interest Expense is 円-10.18 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ribomic Business Description

Address 3-16-13 Usui Building, Shirokanedai, Minato-ku, Tokyo, JPN, 108-0071
Ribomic Inc is a biopharmaceutical venture company based in Tokyo. The company is developing molecular targeted pharmaceutical drugs using RNA aptamers with its unique and advanced platform technologies, the RiboART System.
25GF Score

Get the complete analysis for TSE:4591

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円63.00
Price